Medication-associated diethylene glycol mass poisoning: A review and discussion on the origin of contamination

Journal of Public Health Policy

Volumn 30, Issue 2, 2009, Pages 127-143

  Schier, Joshua G ^a   Rubin, Carol S ^a   Miller, Dorothy ^b   Barr, Dana ^a   McGeehin, Michael A ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Diethylene glycol; Mass poisoning; Poisoning

Indexed keywords

DIETHYLENE GLYCOL; ETHYLENE GLYCOL DERIVATIVE;

ARTICLE; DANGEROUS GOODS; DRUG CONTAMINATION; FORGERY; HAITI; HUMAN; INTOXICATION; PANAMA; QUALITY CONTROL; UNITED STATES;

DRUG CONTAMINATION; ETHYLENE GLYCOLS; FRAUD; HAITI; HAZARDOUS SUBSTANCES; HUMANS; PANAMA; POISONING; QUALITY CONTROL; UNITED STATES;

EID: 67749133945     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/jphp.2009.2     Document Type: Article

References (49)

1. Geiling, E.M.K. and Cannon, P.R. (1938) Pathologic effects of elixir of sulfanilamide (diethylene glycol) poisoning. JAMA 111: 919-926.
2. Leech, P.N. (1937) Elixir of Sulfanilamide-Massengill. Chemical pharmacologic pathologic and necropsy reports; preliminary toxicity reports on diethylene glycol and sulfanilamide. JAMA 109: 1531-1539.
3. History of the FDA: The 1938 Food, Drug and Cosmetics Act, http://www.fda.gov/oc/ history/historyoffda/section2.html, accessed 8 December 2008.
4. Pandya, S.K. (1988) An unmitigated tragedy. British Medical Journal 297: 117-120.
5. Bowie, M.D. and McKenzie, D. (1972) Diethylene glycol poisoning in children. South African Medical Journal: 931-934.
6. Okuonhghae, H.O., Ighogboja, I.S., Lawson, J.O. and Nwana, E.J.C. (1992) Diethylene glycol poisoning in Nigerian children. Annals of Tropical Paediatrics 12: 235-238.
7. Hanif, M., Mobarak, M.R., Ronan, A., Rahman, D., Donovan Jr., J.J. and Bennish, M.L. (1995) Fatal renal failure caused by diethylene glycol in paracetamol elixir: The Bangladesh epidemic. BMJ 311: 88-91.
8. Cantarell, M.C., Fort, J., Camps, J., Sans, M. and Piera, L. (1987) Acute intoxication due to topical application of diethylene glycol. Annals of Internal Medicine 106: 478-479.
9. Drut, R., Quijano, G., Jones, M.C. and Scanferla, P. (1994) Hallazgos patologicos en la intoxicacion por dietilenglicol. Medicina (Buenos Aires) 54: 1-5.
10. Ferrari, L.A. and Giannuzzi, L. (2005) Clinical parameters postmortem analysis and estimation of lethal dose in victims of a massive intoxication with diethylene glycol. Forensic Science International 153: 45-51.
11. O'Brien, K.L. et al (1995) Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. JAMA 279: 1175-1180.
12. Singh, J. et al (2001) Diethylene glycol poisoning in Gurgaon, India 1998. Bulletin of the World Health Organization 79: 88-95.
13. Hari, P., Jain, Y. and Kabra, S.K. (2006) Fatal encephalopathy and renal failure caused by diethylene glycol poisoning. Journal of Tropical Pediatrics 52: 442-444.
14. Junod, S.W. (2000) Diethylene glycol deaths in Haiti. Public Health Reports 115: 78-86.
15. Schier, J.G. and Algren, A. (2007) Medical toxicology and public health - Update on research and activities at the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Journal of Medical Toxicology 3: 85-86.
16. The CNA Corporation. After action report on HHS's response to the 2006 diethylene glycol poisonings in the Republic of Panama. IPR 12272/Draft, March 2007.
17. (2004) Pilosuryl and severe diethylene glycol intoxication. Prescrire International 13: 99.
18. Calvery, H.O. and Klumpp, T.G. (1939) The toxicity for human beings of diethylene glycol with sulfanilamide. Southern Medical Journal 32: 1105-1109.
19. Barr, D.B. et al (2007) Identification and quantification of diethylene glycol in pharmaceuticals implicated in poisoning epidemics: An historical laboratory perspective. Journal of Analytical Toxicology 31: 295-303.
20. Overkamp, K.M., Bakker, B.M., Kotter, P., Luttik, M.A.H., Van Dijken, J.P. and Pronk, J.T. (2002) Metabolic engineering of glycerol production in Saccharomyces cerevisiae. Applied and Environmental Microbiology 68: 2814-2821.
21. Cockburn, R., Newton, P.N., Agyarko, E.K., Akunyili, D. and White, N.J. (2005) The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Medicine 2(4): e100, (Epub 2005, 14 March).
22. Jungermann, E. and Sonntag, N.O.V. (eds.) (1991) Glycerine: A Key Cosmetic Ingredient. New York: Marcel Dekker.
23. Rehm, H.J. (2001) Microbial Production of Glycerol and other Polyols. In: H.J. Rehm, G. Reed, A. Pühler and P. Stadler (eds.) Biotechnology 2001, 2nd edn. New York: Wiley-VCH Publishing.
24. Wang, Z.X., Zhuge, J., Fang, H. and Prior, B.A. (2001) Glycerol production by microbial fermentation: A review. Biotechnology Advances 19: 201-223.
25. Spencer, J.F.T. and Spencer, D.M. (1978) Production of Polyhydroxy Alcohols by Osmotolerant Yeasts. In: A.H. Rose (ed.) Economic Microbiology, Vol. 2. London: Academic Press.
26. Harbison, R.D. (1998) Alcohols and Glycols. In: R.D. Harbison (ed.) Hamilton and Hardy's Industrial Toxicology, 5th edn. New York: Mosby, pp. 217-235.
27. The Innovation Group. Propylene glycol, http://www.the-innovation-group. com/Chem-Profiles/Propylene%20Glycol.htm, accessed 6 April 2007.
28. Shell Chemicals. Product overview. Propylenel glycol, http://www.shellchemicals.com/ propylene-glycol/1,1098,1510,00.html, accessed 10 April 2007.
29. ATSDR. Toxicological profile for ethylene glycol and propylene glycol, http://www.atsdr. cdc.gov/toxprofiles/tp96.html, accessed 3 April 2007.
30. World Health Organization. (1998) General policy issues. WHO Drug Information 12: 129-135.
31. Bogdanich, W. and Hooker, J. From China to Panama a trail of poisoned medicine, www.nytimes.com/2007/05/06/world/06poison.html?em&ex= 1178596800&en=9db5ef 3209b83e97&ei=5087%0, accessed 5 September 2007.
32. United States Food and Drug Administration - Forensic Chemistry Center. (1996) Report on Haitian Samples - Preliminary Results, 31 October.
33. Baffi, P., Elneser, S., Baffi, M. and De Melin, M. (2000) Quantitative determination of diethylene glycol contamination in pharmaceutical products. Journal of AOAC International 83: 793-801.
34. Taherzadeh, M.J., Adler, L. and Liden, G. (2002) Strategies for enhancing fermentative production of glycerol - A review. Enzyme and Microbial Technology 31: 53-66.
35. Biebl, H. (2001) Fermentation of glycerol by Clostridium pasteurianum - Batch and continuous culture studies. Journal of Industrial Microbiology and Biotechnology 27: 18-26.
36. Cronwright, G.R., Rohwer, J.M. and Prior, B.A. (2002) Metabolic control analysis of glycerol synthesis in Saccharomyces cerevisiae. Applied and Environmental Microbiology 68: 4448-4456.
37. Remize, F., Roustan, J.L., Sablayrolles, J.M., Barre, P. and Dequin, S. (1999) Glycerol overproduction by engineered Saccharomyces cerevisiae wine yeast strains leads to substantial changes in by-product formation and to a stimulation of fermentation rate in stationary phase. Applied and Environmental Microbiology 65: 143-149.
38. Dow. Product safety: Propylene glycol, http://www.dow.com/productsafety/ finder/prog. htm#Manufacture, accessed 6 April 2007.
39. Boganich, W. Chinese chemicals flow unchecked onto world drug market, 2007/10/31/ world/asia/31chemical|.html?-r=1&ex=1194667200&en= e80f8502f76576d3&ei=5070 &emc=eta1&oref=slogin, accessed 17 November 2007.
40. About USP: An overview, http://www.usp.org/aboutUSP/, accessed 3 April 2007.
41. Title 21: Food and Drugs. Chapter I - Food and Drug Administration, Department of Health and Human Services. Part 211 - Current good manufacturing practices for finished pharmaceuticals, http://www.access.gpo.gov/nara/cfr/ waisidx-00/21cfr211-00. html, accessed 3 April 2007.
42. US Code Home - Title 21: Food and Drugs, http://www.access.gpo.gov/ uscode/title21/ chapter9-html, accessed 3 April 2007.
43. British Pharmacopoeia. (2007) http://www.pharmacopoeia.co.uk/, accessed 3 April 2007.
44. FDA. Drug application approval 501(b) policy, http://www.fda.gov/cder/ mapp/7211-1. pdf, accessed 19 April 2007.
45. FDA. Part 211 - Current good manufacturing practice for finished pharmaceuticals, http:// www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?fr=211.84, accessed 11 June 2007.
46. United States Food and Drug Administration. Guidance for industry testing of glycerin for diethylene glycol, http://www.fda.gov/cder/guidance/7654fnl. htm, accessed 8 December 2008.
47. WHO. Good Manufacturing Practices: Main principles for pharmaceutical products, http://whqlibdoc.who.int/publications/2004/9241546190-part1.pdf, accessed 3 April 2007.
48. WHO. Control and safe trade of starting materials for pharmaceutical products, http:// www.who.int/medicines/publications/qa-starter/en/, accessed 3 April 2007.
49. Kei Kishimoto, T., Viswanathan, K. and Ganguly, T. et al (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. New England Journal of Medicine 358: 2457-2467.